Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 802

1.

Photorhabdus luminescens Tc toxin is inhibited by the protease inhibitor MG132 and activated by protease cleavage resulting in increased binding to target cells.

Ost GS, Ng'ang'a PN, Lang AE, Aktories K.

Cell Microbiol. 2018 Nov 15:e12978. doi: 10.1111/cmi.12978. [Epub ahead of print]

PMID:
30431706
2.

Opsoclonus-myoclonus-encephalopathy induced by cefepime.

Lizarraga KJ, Heros DO, Adams D, Lang AE, Kanner AM.

J Neurol Sci. 2018 Nov 1;396:33-35. doi: 10.1016/j.jns.2018.10.028. [Epub ahead of print] No abstract available.

PMID:
30412900
3.

Soft signs in movement disorders: friends or foes?

Fearon C, Espay AJ, Lang AE, Lynch T, Martino D, Morgante F, Quinn NP, Vidailhet M, Fasano A.

J Neurol Neurosurg Psychiatry. 2018 Nov 8. pii: jnnp-2018-318455. doi: 10.1136/jnnp-2018-318455. [Epub ahead of print] No abstract available.

PMID:
30409889
4.

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D.

Mov Disord. 2018 Nov 2. doi: 10.1002/mds.27488. [Epub ahead of print]

PMID:
30387904
5.

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease.

Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C.

Mov Disord Clin Pract. 2017 Nov 27;5(1):66-74. doi: 10.1002/mdc3.12563. eCollection 2018 Jan-Feb.

PMID:
30363445
6.

Therapeutic trial design for frontotemporal dementia and related disorders.

Desmarais P, Rohrer JD, Nguyen QD, Herrmann N, Stuss DT, Lang AE, Boxer AL, Dickerson BC, Rosen H, van Swieten JC, Meeter LH, Borroni B, Tartaglia MC, Feldman HH, Black SE, Masellis M.

J Neurol Neurosurg Psychiatry. 2018 Oct 25. pii: jnnp-2018-318603. doi: 10.1136/jnnp-2018-318603. [Epub ahead of print]

PMID:
30361298
7.

Levodopa-induced dyskinesia in Parkinson disease: Current and Evolving Concepts.

Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE.

Ann Neurol. 2018 Oct 24. doi: 10.1002/ana.25364. [Epub ahead of print] Review.

PMID:
30357892
8.

Systematic review of movement disorders and oculomotor abnormalities in Whipple's disease.

Bally JF, Méneret A, Roze E, Anderson M, Grabli D, Lang AE.

Mov Disord. 2018 Oct 19. doi: 10.1002/mds.27419. [Epub ahead of print]

PMID:
30338868
9.

Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease.

Arora S, Visanji NP, Mestre TA, Tsanas A, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Lang AE, Little MA, Marras C.

J Parkinsons Dis. 2018;8(4):503-510. doi: 10.3233/JPD-181389.

PMID:
30248062
10.

Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.

Levy A, Lang AE.

Mov Disord. 2018 Aug;33(8):1372. doi: 10.1002/mds.27449. Epub 2018 Jul 30. No abstract available.

PMID:
30230625
11.

Movement disorder society criteria for clinically established early Parkinson's disease.

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB.

Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.

PMID:
30145841
12.

Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice.

Mestre TA, Shamy M, Benedetti F, Lang AE.

Mov Disord. 2018 Aug;33(8):1195-1203. doi: 10.1002/mds.27409. Epub 2018 Aug 25. Review.

PMID:
30145820
13.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

PMID:
30145797
14.

[18 F]AV-1451 binding and postmortem pathology of CBD.

Coakeley S, Ang LC, Jansen GH, Cho SS, Lang AE, Houle S, Kalia LV, Strafella AP.

Mov Disord. 2018 Aug;33(8):1360-1361. doi: 10.1002/mds.27356. Epub 2018 Aug 23. No abstract available.

PMID:
30136331
15.

Workstation configuration and container type influence upper limb posture in grocery bagging.

Lang AE, Maciukiewicz JM, Vidt ME, Grenier SG, Dickerson CR.

Appl Ergon. 2018 Nov;73:206-213. doi: 10.1016/j.apergo.2018.07.012. Epub 2018 Jul 30.

PMID:
30098637
16.

Brain tissue pulsatility is related to clinical features of Parkinson's disease.

Shirzadi Z, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ.

Neuroimage Clin. 2018 Jul 23;20:222-227. doi: 10.1016/j.nicl.2018.07.017. eCollection 2018.

17.

Reproducibility of data-driven Parkinson's disease subtypes for clinical research.

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Jul 20. pii: S1353-8020(18)30312-2. doi: 10.1016/j.parkreldis.2018.07.009. [Epub ahead of print]

PMID:
30056038
18.

The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study.

Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, Lynch T, Mohammad SS, Britton F, Evans M, Hacohen Y, Lin JP, Nardocci N, Granata T, Dale RC, Lim MJ, Bhatia KP, Lang AE, Irani SR.

J Neurol Neurosurg Psychiatry. 2018 Jul 21. pii: jnnp-2018-318584. doi: 10.1136/jnnp-2018-318584. [Epub ahead of print] No abstract available.

19.

Essential tremor plus is more common than essential tremor: Insights from the reclassification of a cohort of patients with lower limb tremor.

Rajalingam R, Breen DP, Lang AE, Fasano A.

Parkinsonism Relat Disord. 2018 Jun 21. pii: S1353-8020(18)30291-8. doi: 10.1016/j.parkreldis.2018.06.029. [Epub ahead of print] No abstract available.

PMID:
29958776
20.

Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment.

Roze E, Lang AE, Vidailhet M.

Curr Opin Neurol. 2018 Aug;31(4):484-490. doi: 10.1097/WCO.0000000000000577.

PMID:
29952836
21.

Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.

Schirinzi T, Sancesario GM, Di Lazzaro G, Scalise S, Colona VL, Imbriani P, Mercuri NB, Bernardini S, Lang AE, Pisani A.

J Neural Transm (Vienna). 2018 Sep;125(9):1373-1379. doi: 10.1007/s00702-018-1893-1. Epub 2018 Jun 14.

PMID:
29948175
22.

Pantothenate kinase-associated neurodegeneration mimicking Tourette syndrome: a case report and review of the literature.

Rohani M, Fasano A, Lang AE, Zamani B, Javanparast L, Bidgoli MR, Alavi A.

Neurol Sci. 2018 Jun 21. doi: 10.1007/s10072-018-3472-5. [Epub ahead of print] No abstract available.

PMID:
29926305
23.

Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease.

Tan AH, Hew YC, Lim SY, Ramli NM, Kamaruzzaman SB, Tan MP, Grossmann M, Ang BH, Tan JY, Manap MAAA, Tay TK, Tan SL, New RP, Fadzli F, Yee EJ, Moy FM, Mahadeva S, Lang AE.

Parkinsonism Relat Disord. 2018 Jun 13. pii: S1353-8020(18)30279-7. doi: 10.1016/j.parkreldis.2018.06.020. [Epub ahead of print]

PMID:
29914840
24.

Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.

Johnston TH, Lacoste AMB, Visanji NP, Lang AE, Fox SH, Brotchie JM.

Neuropharmacology. 2018 Jun 1. pii: S0028-3908(18)30270-3. doi: 10.1016/j.neuropharm.2018.05.035. [Epub ahead of print] Review.

PMID:
29907424
25.

Movement disorders in non-encephalopathic Hashimoto's thyroiditis.

Miranda M, Bustamante ML, Campero M, Wainstein E, Toche P, Espay AJ, Walker RH, Lang AE.

Parkinsonism Relat Disord. 2018 Oct;55:141-142. doi: 10.1016/j.parkreldis.2018.06.008. Epub 2018 Jun 5. No abstract available.

PMID:
29887356
26.

Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, LaFaver K, LaFrance WC Jr, Lang AE, Nicholson T, Nielsen G, Reuber M, Voon V, Stone J, Morgante F.

JAMA Neurol. 2018 Sep 1;75(9):1132-1141. doi: 10.1001/jamaneurol.2018.1264.

PMID:
29868890
27.

Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Butcher NJ, Boot E, Lang AE, Andrade D, Vorstman J, McDonald-McGinn D, Bassett AS.

Am J Med Genet A. 2018 Oct;176(10):2146-2159. doi: 10.1002/ajmg.a.38708. Epub 2018 May 19.

PMID:
29777584
28.

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.

Kim KS, Marcogliese PC, Yang J, Callaghan SM, Resende V, Abdel-Messih E, Marras C, Visanji NP, Huang J, Schlossmacher MG, Trinkle-Mulcahy L, Slack RS, Lang AE; Canadian Lrrk2 in Inflammation Team (CLINT), Park DS.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5164-E5173. doi: 10.1073/pnas.1718946115. Epub 2018 May 14.

PMID:
29760073
29.

Diagnostic criteria for camptocormia in Parkinson's disease: A consensus-based proposal.

Fasano A, Geroin C, Berardelli A, Bloem BR, Espay AJ, Hallett M, Lang AE, Tinazzi M.

Parkinsonism Relat Disord. 2018 Aug;53:53-57. doi: 10.1016/j.parkreldis.2018.04.033. Epub 2018 May 8.

PMID:
29759930
30.

Sleep-related motor and behavioral disorders: Recent advances and new entities.

Breen DP, Högl B, Fasano A, Trenkwalder C, Lang AE.

Mov Disord. 2018 Jul;33(7):1042-1055. doi: 10.1002/mds.27375. Epub 2018 May 14. Review.

PMID:
29756278
31.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 Jun 5;90(23):e2059-e2067. doi: 10.1212/WNL.0000000000005660. Epub 2018 May 11.

32.

Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

Martinez M, Multani N, Anor CJ, Misquitta K, Tang-Wai DF, Keren R, Fox S, Lang AE, Marras C, Tartaglia MC.

Front Aging Neurosci. 2018 Apr 24;10:120. doi: 10.3389/fnagi.2018.00120. eCollection 2018.

33.

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.

Mestre TA, Pont-Sunyer C, Kausar F, Visanji NP, Ghate T, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kasten M, Wadia PM, Zadikoff C, Kumar P, de Bie RM, Thomsen T, Lang AE, Schüle B, Klein C, Tolosa E, Marras C.

Mov Disord. 2018 Jul;33(6):960-965. doi: 10.1002/mds.27272. Epub 2018 Apr 17.

PMID:
29665080
34.

Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations.

Lang AE, Espay AJ.

Mov Disord. 2018 May;33(5):660-677. doi: 10.1002/mds.27360. Epub 2018 Apr 11. Review.

PMID:
29644751
35.

Oculogyric crises in PLA2G6 associated neurodegeneration.

Rohani M, Shahidi G, Vali F, Lang AE, Slow E, Gahl WA, Behnam B.

Parkinsonism Relat Disord. 2018 Jul;52:111-112. doi: 10.1016/j.parkreldis.2018.03.010. Epub 2018 Mar 17. No abstract available.

PMID:
29574084
36.

A 21-Year Retrospective Study of the Toronto Western Hospital Deep Brain Stimulation Cohort.

Cubo E, Rajalingam R, Fasano A, Munhoz RP, Lang AE, Calvo S, Marras C.

Mov Disord. 2018 May;33(5):850-852. doi: 10.1002/mds.27359. Epub 2018 Mar 23. No abstract available.

PMID:
29570864
37.

Functional neurological disorders in Parkinson disease.

Wissel BD, Dwivedi AK, Merola A, Chin D, Jacob C, Duker AP, Vaughan JE, Lovera L, LaFaver K, Levy A, Lang AE, Morgante F, Nirenberg MJ, Stephen C, Sharma N, Romagnolo A, Lopiano L, Balint B, Yu XX, Bhatia KP, Espay AJ.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):566-571. doi: 10.1136/jnnp-2017-317378. Epub 2018 Mar 16.

PMID:
29549192
38.

Actigraphy Detects Greater Intra-Individual Variability During Gait in Non-Manifesting LRRK2 Mutation Carriers.

van den Heuvel L, Lim AS, Visanji NP, Huang J, Ghate T, Mestre TA, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Pondal M, Faust-Socher A, Rogaeva E, Tomlinson G, Lang AE, Marras C.

J Parkinsons Dis. 2018;8(1):131-139. doi: 10.3233/JPD-171151.

PMID:
29480219
39.

Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations.

Levy A, Lang AE.

Mov Disord. 2018 Aug;33(8):1238-1247. doi: 10.1002/mds.27319. Epub 2018 Feb 13. Review. Erratum in: Mov Disord. 2018 Aug;33(8):1372.

PMID:
29436738
40.

[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy.

Brendel M, Schönecker S, Höglinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F, Lang AE, Golbe L, Nübling G, Bartenstein P, Furukawa K, Ishiki A, Bötzel K, Danek A, Okamura N, Levin J, Rominger A.

Front Aging Neurosci. 2018 Jan 17;9:440. doi: 10.3389/fnagi.2017.00440. eCollection 2017.

41.

Pallidal deep brain stimulation modulates cortical excitability and plasticity.

Ni Z, Kim SJ, Phielipp N, Ghosh S, Udupa K, Gunraj CA, Saha U, Hodaie M, Kalia SK, Lozano AM, Lee DJ, Moro E, Fasano A, Hallett M, Lang AE, Chen R.

Ann Neurol. 2018 Feb;83(2):352-362. doi: 10.1002/ana.25156.

PMID:
29369401
42.

Infantile-onset hand dystonia with intellectual disability: Clues to ARX mutations.

Breen DP, Mercimek-Andrews S, Lang AE.

Neurology. 2018 Feb 13;90(7):333-335. doi: 10.1212/WNL.0000000000004972. Epub 2018 Jan 17. No abstract available.

PMID:
29343471
43.

Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.

Udow SJ, Freitas ME, Fox SH, Lang AE.

CMAJ. 2018 Jan 15;190(2):E50-E52. doi: 10.1503/cmaj.170361. No abstract available.

PMID:
29335263
44.

What is "essential" about essential tremor? A diagnostic placeholder.

Fasano A, Lang AE, Espay AJ.

Mov Disord. 2018 Jan;33(1):58-61. doi: 10.1002/mds.27288. Epub 2017 Dec 22. No abstract available.

PMID:
29272067
45.

The combined fatigue effects of sequential exposure to seated whole body vibration and physical, mental, or concurrent work demands.

Yung M, Lang AE, Stobart J, Kociolek AM, Milosavljevic S, Trask C.

PLoS One. 2017 Dec 13;12(12):e0188468. doi: 10.1371/journal.pone.0188468. eCollection 2017.

46.

Asymmetric neuromodulation of motor circuits in Parkinson's disease: The role of subthalamic deep brain stimulation.

Lizarraga KJ, Luca CC, De Salles A, Gorgulho A, Lang AE, Fasano A.

Surg Neurol Int. 2017 Oct 24;8:261. doi: 10.4103/sni.sni_292_17. eCollection 2017. Review.

47.

Is there even such a thing as "idiopathic normal pressure hydrocephalus"?

Espay AJ, Lang AE.

Ann Neurol. 2017 Dec;82(6):1032. doi: 10.1002/ana.25097. Epub 2017 Dec 4. No abstract available.

PMID:
29136297
48.

Lymphatic vasculature in human dural superior sagittal sinus: Implications for neurodegenerative proteinopathies.

Visanji NP, Lang AE, Munoz DG.

Neurosci Lett. 2018 Feb 5;665:18-21. doi: 10.1016/j.neulet.2017.11.001. Epub 2017 Nov 11.

PMID:
29133178
49.

Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study.

Espay AJ, Maloney T, Vannest J, Norris MM, Eliassen JC, Neefus E, Allendorfer JB, Lang AE, Szaflarski JP.

Neuroimage Clin. 2017 Oct 18;17:179-187. doi: 10.1016/j.nicl.2017.10.020. eCollection 2018.

50.

Altered gut microbiome and metabolome in patients with multiple system atrophy.

Tan AH, Chong CW, Song SL, Teh CSJ, Yap IKS, Loke MF, Tan YQ, Yong HS, Mahadeva S, Lang AE, Lim SY.

Mov Disord. 2018 Jan;33(1):174-176. doi: 10.1002/mds.27203. Epub 2017 Oct 30. No abstract available.

PMID:
29083071

Supplemental Content

Support Center